← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Palipéridone currently has availability issues reported in 2 European registers: France, Italy.
Shortage ATC — · also listed as: palipéridone · PALIPERIDONE · data refreshed 21 September 2026
As of 21 September 2026, 2 of the 8 tracked registers list current availability issues for Palipéridone, covering 17 affected product presentations. The longest-running open report was filed in Italy on 2024-06-28 and has now been open for about 27 months. Where agencies state a cause, manufacturing problems lead with 9 of the 14 stated-cause reports, followed by unexpectedly high demand with 5. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-09-30. Momentum is current, not historical: 3 of the open reports were filed within the last 90 days. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇫🇷 France | Limited availability Palipéridone BGR, suspension injectable à libération prolongée en seringue préremplie + 3 more productsPalipéridone Biogaran, suspension injectable à libération prolongée en seringue préremplie Palipéridone Teva, suspension injectable à libération prolongée Xeplion, suspension injectable à libération prolongée | — | — | Psychiatrie | register ↗ |
| 🇮🇹 Italy | Shortage PALIPERIDONE KRKA + 13 more productsPALIPERIDONE KRKA PALIPERIDONE KRKA PALIPERIDONE SANDOZ PALIPERIDONE TEVA PALIPERIDONE TEVA ITALIA PALIPERIDONE TEVA ITALIA PALIPERIDONE TEVA ITALIA PALIPERIDONE ZENTIVA PALIPERIDONE ZENTIVA PALMEUX PALMEUX PALMEUX PALMEUX | 2024-06-28 | 2026-12-31 | Problemi produttivi Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
Every individual register entry for Palipéridone in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | PALIPERIDONE ZENTIVA | Shortage | 2026-08-24 | — | Elevata richiesta/problemi produttivi |
| 🇮🇹 IT | PALIPERIDONE ZENTIVA | Shortage | 2026-07-31 | — | Elevata richiesta/problemi produttivi |
| 🇮🇹 IT | PALIPERIDONE TEVA | Shortage | 2026-06-30 | 2026-09-30 | Elevata richiesta |
| 🇮🇹 IT | PALIPERIDONE TEVA ITALIA | Shortage | 2026-03-02 | 2026-10-30 | Elevata richiesta: forniture discontinue |
| 🇮🇹 IT | PALIPERIDONE TEVA ITALIA | Shortage | 2026-02-26 | — | Elevata richiesta |
| 🇮🇹 IT | PALIPERIDONE SANDOZ | Shortage | 2026-02-13 | — | Elevata richiesta/problemi produttivi |
| 🇮🇹 IT | PALIPERIDONE TEVA ITALIA | Shortage | 2026-02-02 | 2026-10-30 | Elevata richiesta: distribuzione contingentata |
| 🇮🇹 IT | PALMEUX | Shortage | 2025-07-17 | 2026-12-31 | Problemi produttivi |
| 🇮🇹 IT | PALIPERIDONE KRKA | Shortage | 2025-07-07 | — | Elevata richiesta |
| 🇮🇹 IT | PALIPERIDONE KRKA | Shortage | 2025-04-17 | — | Problemi produttivi |
| 🇮🇹 IT | PALMEUX | Shortage | 2025-01-10 | 2026-12-31 | Problemi produttivi |
| 🇮🇹 IT | PALMEUX | Shortage | 2024-10-07 | 2026-12-31 | Problemi produttivi |
| 🇮🇹 IT | PALIPERIDONE KRKA | Shortage | 2024-07-19 | — | Problemi produttivi |
| 🇮🇹 IT | PALMEUX | Shortage | 2024-06-28 | 2026-12-31 | Problemi produttivi |
| 🇫🇷 FR | Palipéridone BGR, suspension injectable à libération prolongée en seri | Limited availability | — | — | Psychiatrie |
| 🇫🇷 FR | Palipéridone Biogaran, suspension injectable à libération prolongée en | Discontinued | — | — | Psychiatrie |
| 🇫🇷 FR | Palipéridone Teva, suspension injectable à libération prolongée | Limited availability | — | — | Psychiatrie |
| 🇫🇷 FR | Xeplion, suspension injectable à libération prolongée | Limited availability | — | — | Psychiatrie |
Yes. As of 21 September 2026, availability issues are reported in: France, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-30 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
14 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Palipéridone: ANSM (France), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Palipéridone — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/paliperidone/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Palipéridone availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/paliperidone/">Palipéridone shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>